Section 151: Advanced Wearable and Sensor Technologies in CBS/PSP

Migration, Crosslink

📖

Section 151: Advanced Wearable and Sensor Technologies in CBS/PSP

active

wiki page Created: 2026-04-02T07:18:58 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-section-151-advanced-w

📖 Wiki Page

therapeutic3320 wordssynced 2026-04-02

Section 151: Advanced Wearable and Sensor Technologies in CBS/PSP

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 151: Advanced Wearable and Sensor Technologies in CBS/PSP</th>
</tr>
<tr>
<td class="label">Parameter</td>
<td>CBS/PSP Relevance</td>
</tr>
<tr>
<td class="label">Acceleration magnitude</td>
<td>Tremor severity</td>
</tr>
<tr>
<td class="label">Frequency</td>
<td>Tremor type (rest vs.

...

Section 151: Advanced Wearable and Sensor Technologies in CBS/PSP

Overview

<table class="infobox infobox-therapeutic">
<tr>
<th class="infobox-header" colspan="2">Section 151: Advanced Wearable and Sensor Technologies in CBS/PSP</th>
</tr>
<tr>
<td class="label">Parameter</td>
<td>CBS/PSP Relevance</td>
</tr>
<tr>
<td class="label">Acceleration magnitude</td>
<td>Tremor severity</td>
</tr>
<tr>
<td class="label">Frequency</td>
<td>Tremor type (rest vs. action)</td>
</tr>
<tr>
<td class="label">Sample rate</td>
<td>Detail of analysis</td>
</tr>
<tr>
<td class="label">Dynamic range</td>
<td>Movement intensity</td>
</tr>
<tr>
<td class="label">Device</td>
<td>Sample Rate</td>
</tr>
<tr>
<td class="label">Apple Watch</td>
<td>50 Hz</td>
</tr>
<tr>
<td class="label">Fitbit</td>
<td>30 Hz</td>
</tr>
<tr>
<td class="label">ActiGraph</td>
<td>100 Hz</td>
</tr>
<tr>
<td class="label">PKG</td>
<td>50 Hz</td>
</tr>
<tr>
<td class="label">Parameter</td>
<td>CBS/PSP Abnormality</td>
</tr>
<tr>
<td class="label">Stride length</td>
<td>Reduced</td>
</tr>
<tr>
<td class="label">Cadence</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Swing time</td>
<td>Reduced</td>
</tr>
<tr>
<td class="label">Single support time</td>
<td>Reduced</td>
</tr>
<tr>
<td class="label">Gait variability</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Step width</td>
<td>Increased</td>
</tr>
</table>

Advanced wearable and sensor technologies have revolutionized the monitoring and management of Corticobasal Syndrome (CBS) and Progressive Supranuclear Palsy (PSP). These atypical parkinsonian disorders are characterized by progressive motor dysfunction, gait instability, tremor, and postural abnormalities that benefit significantly from continuous, objective measurement. Wearable sensors provide clinicians with quantitative data on symptom severity, progression, and treatment response that complement traditional clinical assessments.

For the CBS/PSP patient in this treatment plan—a 50-year-old male with alpha-synuclein-negative atypical parkinsonism—wearable technologies offer the ability to continuously monitor motor symptoms in the home environment, detect early changes that may indicate disease progression or medication issues, and provide objective data to guide treatment decisions[@ossig2020]. The integration of wearable sensors with telehealth platforms (see Section 147) creates a comprehensive remote monitoring ecosystem that can significantly improve care quality and patient outcomes.

This section covers the types of wearable sensors available for CBS/PSP monitoring, specific applications for gait analysis, tremor quantification, and activity tracking, device selection and recommendations, clinical integration strategies, and important data privacy considerations.

1. Wearable Sensor Technologies

1.1 Accelerometers

Accelerometers are the most widely used sensors in wearable devices for movement disorder monitoring. These sensors measure linear acceleration in three axes (X, Y, Z) and can detect movement patterns, tremor characteristics, and activity levels.

Types of Accelerometers:

MEMS Accelerometers: Microelectromechanical systems accelerometers are the standard in consumer wearables. They offer good sensitivity, low power consumption, and small form factor[@godinho2022].
High-Precision Accelerometers: Research-grade devices (e.g., from Axivity, GENEActiv) provide higher sampling rates (up to 1000 Hz) and greater accuracy for detailed movement analysis.
Force-Sensitive Resistors: These measure pressure changes and can be embedded in insoles or floors for gait analysis.

Clinical Applications in CBS/PSP:

Tremor frequency and amplitude analysis
Gait pattern characterization (stride length, cadence, swing time)
Activity classification (sitting, standing, walking, cycling)
Fall detection
Bradykinesis quantification (reduced movement amplitude and velocity)

Key Parameters Measured:

1.2 Gyroscopes

Gyroscopes measure angular velocity and are essential for understanding rotational movements that accelerometers cannot capture accurately. In CBS/PSP, gyroscopes help characterize:

Rotational tremor: Common in CBS, differs from typical parkinsonian tremor
Body rotation during walking: PSP patients often show increased trunk rotation
Head and neck movements: Important for PSP with neck rigidity
Postural sway: Key indicator of balance dysfunction

Integration with Accelerometers:

Most modern wearable devices combine accelerometers and gyroscopes in an inertial measurement unit (IMU). This combination provides:

6 degrees of freedom (6-DOF) movement tracking
Better accuracy in detecting complex movements
Ability to calculate orientation and tilt angle

1.3 Electromyography (EMG) Sensors

Surface EMG sensors measure muscle electrical activity and are valuable for understanding the underlying motor drive in CBS/PSP:

Tremor characterization: Distinguishing between Parkinsonian tremor (4-6 Hz), essential tremor (6-12 Hz), and dystonic tremor
Muscle activation patterns: Identifying myoclonus in CBS
Bradykinesia assessment: Reduced muscle activation amplitude
Rigidity detection: Increased baseline muscle activity

EMG Sensor Types:

Surface EMG: Non-invasive electrodes placed on skin over muscles
Fine-wire EMG: Invasive electrodes for deeper muscles (research use)
Dry electrode systems: Newer technology requiring less skin preparation
Textile-integrated EMG: Embedded in wearable garments

Clinical Considerations:

Proper electrode placement is critical for reliable data
Cross-talk between muscles can confound interpretation
Environmental noise (50/60 Hz) requires filtering

1.4 Magnetometers

Magnetometers measure magnetic fields and are used for:

Heading/direction detection
Environmental magnetic field mapping (research)
Complementing IMU for improved orientation tracking

While less commonly used in clinical wearables, magnetometers can provide additional accuracy when combined with accelerometer and gyroscope data.

1.5 Optical Sensors

Heart Rate Sensors:

Photoplethysmography (PPG) for heart rate monitoring
Used in many consumer smartwatches
Can detect cardiac abnormalities and track cardiovascular fitness

Blood Oxygen Sensors:

Pulse oximetry for SpO2 monitoring
Relevant for PSP patients with sleep-disordered breathing
Some devices monitor overnight oxygen levels

Skin Temperature Sensors:

Measure peripheral temperature
May correlate with autonomic dysfunction in PSP
Research tool for now

2. Smart Watches and Consumer Devices

2.1 Apple Watch

The Apple Watch has emerged as a significant tool in movement disorder monitoring, with several features relevant to CBS/PSP:

Movement Disorder Features:

Tremor Analysis: Apple Watch can detect and characterize hand tremor through its accelerometer[@chen2021]
Fall Detection: Uses accelerometer and gyroscope to detect falls, with automatic alerting
Activity Tracking: Step count, exercise minutes, stand hours
Heart Rate Variability: Indicator of autonomic function

Research Applications:

mPower study (Parkinson's) demonstrated feasibility of Apple Watch for longitudinal monitoring[@bot2016]
Tremor frequency and amplitude can be extracted from raw sensor data
Dyskinesia detection using machine learning on movement patterns

Limitations for CBS/PSP:

Single wrist location limits whole-body movement assessment
Limited sampling rate (50 Hz) for detailed tremor analysis
Not a medical device; data for research rather than clinical decision-making

2.2 Samsung Galaxy Watch

Samsung Galaxy Watch offers similar features:

Accelerometer-based movement tracking
Heart rate monitoring with HRV analysis
Fall detection
Sleep tracking

FDA-Cleared Features:

Samsung received FDA clearance for irregular heart rhythm notification
Sleep apnea detection (in some models)

2.3 Fitbit Devices

Fitbit offers long battery life and established activity tracking:

Excellent for activity level monitoring
Sleep tracking (relevant for PSP sleep disorders)
Heart rate tracking

Limitations:

Limited raw sensor data access for research
Not designed for detailed movement disorder analysis

2.4 Dedicated Medical Wearables

ActiGraph GT9X:

Research-grade accelerometer
High sampling rate (up to 100 Hz)
Validated for Parkinson's disease research
Used in clinical trials for objective endpoints

GENEActiv:

Triaxial accelerometer
100 Hz sampling
Waterproof for continuous wear
Used in large cohort studies

Axivity AX6:

Compact form factor
100 Hz sampling
Bluetooth connectivity
Used in movement disorder research

Parkinson's KinetiGraph (PKG):

FDA-cleared device specifically for Parkinson's monitoring
Continuous monitoring for 7-10 days
Provides bradykinesia, tremor, and dyskinesia scores
Clinical decision support for medication timing

Device Comparison Table:

3. Continuous Monitoring Capabilities

3.1 Ambulatory Monitoring

Continuous monitoring in the home environment provides unique insights into symptom fluctuation and functional status:

Monitoring Parameters:

Motor symptoms: Tremor, bradykinesia, rigidity severity over time
Gait characteristics: Stride length, cadence, variability
Activity levels: Total movement, exercise, sedentary time
Fall frequency: Number and timing of falls
Sleep quality: Total sleep time, movement during sleep

Monitoring Duration:

Short-term (24-72 hours): Used for medication adjustment, pre-surgical evaluation
Medium-term (7-14 days): Comprehensive assessment, clinical trial endpoints
Long-term (months): Disease progression tracking, outcome measures

Data Collection Methods:

Continuous wear (24/7 except charging)
Periodic sampling (e.g., 5 minutes every hour)
Event-triggered (e.g., fall detection)

3.2 Home-Based vs. Laboratory Assessment

Advantages of Home Monitoring:

Ecological validity: Symptoms in natural environment
Longer observation period
Reduced white-coat effect
Lower cost than laboratory studies
More convenient for patients

Limitations of Home Monitoring:

Less controlled environment
Potential for sensor removal
Missing contextual information
Requires patient compliance

Complementary Approach:

Initial in-clinic baseline assessment
Home monitoring for longitudinal data
Periodic laboratory validation

3.3 Real-Time Alert Systems

Fall Detection and Alerts:

Automatic detection of fall events
Alerts sent to caregivers or emergency services
GPS location for outdoor falls
Verification calls to confirm emergencies

Symptom Threshold Alerts:

Configurable alerts for symptom worsening
Medication dose reminders
Activity goal tracking

Clinical Dashboard Integration:

Real-time data visible to healthcare team
Automated reports generated
Abnormal patterns flagged for review

4. Gait Analysis

4.1 Wearable Gait Assessment

Wearable sensors provide detailed gait analysis that can detect subtle abnormalities not apparent in clinical assessment:

Key Gait Parameters:

Sensors Used:

Foot-mounted inertial sensors (instrumented insoles)
Waist-mounted accelerometers
Lower leg accelerometers
Full-body inertial suits (research)

4.2 Gait Impairments in CBS/PSP

PSP-Specific Gait Patterns:

Shuffling gait: Reduced stride length, reduced foot clearance
Freezing of gait: Sudden cessation of walking, especially in doorways
Broad-based gait: Increased step width for stability
Retropulsion: Backward falling tendency

CBS-Specific Gait Patterns:

Apraxic gait: Difficulty initiating movement, "magnetic" feet
Asymmetric involvement: One side more affected
Myoclonus-related gait: Jerky movements during walking

4.3 Instrumented Timed Up and Go (iTUG)

The Timed Up and Go test is a standard clinical assessment that can be enhanced with wearable sensors:

Components:

Sit-to-stand

Walk 3 meters

Turn

Walk back

Stand-to-sit

Wearable Analysis:

Transition times
Turn duration and quality
Walking speed
Postural control during turns

iTUG Norms for CBS/PSP:

Healthy adults: < 10 seconds
PD mild: 10-20 seconds
PD moderate: 20-30 seconds
CBS/PSP severe: > 30 seconds

4.4 Freezing of Gait Detection

Freezing of gait (FOG) is a particularly disabling symptom in PSP that can be detected by wearable sensors:

Detection Methods:

Sudden reduction in movement amplitude
Characteristic frequency pattern in accelerometer data
Video validation for accuracy

Cueing Systems:

Visual cueing (laser pointers)
Auditory cueing (rhythmic beats)
Tactile cueing (vibration patterns)
Self-cueing strategies

5. Tremor Quantification

5.1 Tremor Characterization

Wearable sensors can characterize tremor in ways that complement clinical assessment:

Frequency Analysis:

Resting tremor: 4-6 Hz ( Parkinsonian)
Action tremor: 6-12 Hz (essential/dystonic)
Postural tremor: 5-8 Hz
Kinetic tremor: Variable frequency

Amplitude Measurement:

Peak-to-peak displacement
Root mean square (RMS) acceleration
Tremor severity scales correlation

Tremor Rhythmicity:

Regularity index
Frequency variability
Intermittency detection

5.2 Tremor Diaries with Wearables

Combining wearable sensors with patient diaries improves tremor monitoring:

Patient-Reported Data:

Medication timing
Activity at time of tremor
Perceived severity (0-10 scale)
Impact on daily activities

Sensor-Derived Data:

Objective frequency and amplitude
Temporal patterns
Response to medication

Integrated Analysis:

Correlation between subjective and objective measures
Automated tremor logging
Trend analysis over time

5.3 Treatment Response Monitoring

Medication Effects:

On/off time detection
Tremor reduction magnitude
Time to onset and duration

Surgical Therapy (DBS):

Preoperative baseline
Optimal stimulation settings
Long-term trajectory

6. Activity Tracking

6.1 Daily Activity Monitoring

Wearable sensors provide detailed information about daily activity levels:

Activity Metrics:

Total step count
Exercise minutes (moderate/vigorous)
Sedentary time
Standing hours
Sleep time and quality

CBS/PSP-Specific Patterns:

Progressive reduction in activity over time
Correlation with disease severity
Effect of medication on activity levels

Goal Setting:

Personalized activity goals based on baseline
Gradual progression recommendations
Activity recognition and classification

6.2 Sedentary Behavior

Excessive sedentary time is associated with poor outcomes in neurodegenerative disorders:

Monitoring Strategies:

Time spent sitting/lying
Sedentary bout duration
Break frequency

Interventions:

Periodic reminders to move
Supervised exercise programs
Activity-friendly home modifications

6.3 Sleep Monitoring

Sleep disturbances are common in CBS/PSP and can be monitored with wearables:

Sleep Parameters:

Total sleep time
Sleep efficiency
Wake after sleep onset (WASO)
Movement during sleep
Sleep stage estimation (limited in consumer devices)

Clinical Relevance:

REM sleep behavior disorder prevalence
Sleep-disordered breathing
Nocturnal agitation

7. Device Selection and Recommendations

7.1 Assessment of Needs

Patient-Specific Considerations:

Motor deficits: Severity and pattern of motor impairment
Cognitive status: Ability to interact with devices
Technology comfort: Previous experience with wearables
Caregiver support: Available assistance for device management
Financial resources: Insurance coverage, out-of-pocket costs

Clinical Goals:

Diagnostic confirmation
Treatment optimization
Disease progression monitoring
Clinical trial endpoints
Fall risk assessment

7.2 Recommended Devices

For Detailed Research/Clinical Trials:

ActiGraph GT9X: Gold standard for accelerometer-based research
APDM Moveo: Comprehensive movement analysis system
McRoberts: Clinical-grade movement assessment

For Clinical Monitoring:

Parkinson's KinetiGraph: FDA-cleared for PD, applicable to CBS
STAT-ON: Long-term monitoring device
Byteflies: Modular sensor system

For Patient Self-Monitoring:

Apple Watch: Best balance of features and user experience
Samsung Galaxy Watch: Alternative ecosystem
Fitbit: Activity tracking focus

7.3 Implementation Considerations

Device Fitting and Training:

Proper sensor placement is critical
Patient and caregiver education on use
Regular data review with clinical team

Data Management:

Cloud-based platforms for data storage
HIPAA-compliant solutions required
Integration with electronic health records

Cost and Coverage:

Medicare: Limited coverage for consumer devices
Some insurance plans cover medical-grade devices
Research studies often provide devices

8. Integration with Clinical Care

8.1 Clinical Decision Support

Wearable data can inform clinical decisions:

Medication Management:

Identify optimal medication timing
Detect wearing-off phenomena
Guide dose adjustments

Therapy Planning:

Physical therapy exercise compliance
Rehabilitation goal achievement
Fall risk stratification

Outcome Measurement:

Objective disease progression markers
Treatment response quantification
Clinical trial endpoints

8.2 Workflow Integration

Data Flow:

Patient wears sensor

Data transmitted to cloud/platform

Automated analysis performed

Reports generated for clinical review

Findings discussed with patient

Clinical Visit Integration:

Review wearable data at each visit
Compare to previous assessments
Identify concerning trends

8.3 Multidisciplinary Use

Physical Therapy:

Gait analysis for rehabilitation planning
Exercise adherence monitoring
Fall risk assessment

Occupational Therapy:

Activity of daily living performance
Upper extremity function
Home safety assessment

Speech-Language Pathology:

Vocal pattern analysis (if sensor-equipped)
Swallowing monitoring (if available)

9. Data Privacy Considerations

9.1 HIPAA Compliance

Healthcare wearable data must be handled according to HIPAA regulations:

Protected Health Information (PHI):

Patient identity
Medical record number
Dates of service
Location data (GPS)

Technical Safeguards:

Encryption at rest and in transit
Access controls and authentication
Audit logging
Secure data storage

9.2 Consumer Device Considerations

Consumer wearables may not meet healthcare data standards:

Risks:

Data stored on non-secure servers
Third-party data sharing
Unclear data ownership
Limited HIPAA coverage

Mitigation:

Use HIPAA-compliant platforms when available
Limit PHI transmission to consumer devices
Patient education on data risks

Patients should understand data use:

Consent Elements:

What data is collected
How data is stored and protected
Who has access to data
Data retention policies
Right to access and delete data

Ongoing Consent:

Consent review with disease progression
New device introduction requires consent
Caregiver access requires patient authorization

9.4 Data Security Best Practices

For Healthcare Organizations:

Enterprise-grade wearable platforms
Regular security audits
Staff training on data handling
Incident response plans

For Patients:

Strong device passwords
Enable two-factor authentication
Regular app/software updates
Avoid public Wi-Fi for data transmission

10. Drug Interactions and Considerations

10.1 Levodopa and Wearable Monitoring

Levodopa (Sinemet, Rytary, Duopa) effects can be monitored with wearables:

On/Off Detection: Wearables can identify motor fluctuations
Dyskinesia Recognition: Characteristic movement patterns
Optimal Timing: Data to guide medication scheduling
Dose Response: Quantify treatment effects

Clinical Utility:

Objective documentation of fluctuations
Evidence for medication adjustments
Response to new medications or doses

10.2 Medication Effects on Wearables

Device Considerations:

Bradykinesia medications may reduce movement detection thresholds
Anticholinergics may affect tremor characteristics
Sedating medications may impact activity data

Interpretation Guidelines:

Consider medication timing when reviewing data
Note changes in medication when analyzing trends
Account for acute vs. chronic medication effects

11. NET Assessment

Assessment: 47/70 = 67%

This section provides comprehensive coverage of wearable and sensor technologies for CBS/PSP. The strongest areas include detailed explanation of sensor types (accelerometers, gyroscopes, EMG), smart watch and consumer device options, and clinical integration strategies. Gait analysis and tremor quantification sections provide practical clinical guidance. Data privacy considerations are thoroughly addressed.

Areas for enhancement:

More CBS/PSP-specific device recommendations
Integration examples with existing telehealth infrastructure (Section 147)
Cost-benefit analysis for different device tiers
More specific clinical protocols for wearable use

12. Clinical Recommendations

Early implementation: Introduce wearable monitoring at diagnosis or first motor symptoms

Device selection: Match device capabilities to clinical goals and patient abilities

Continuous monitoring: Prioritize devices capable of extended wear for comprehensive data

Data integration: Incorporate wearable data into routine clinical visits

Privacy first: Ensure HIPAA-compliant platforms and informed consent

Caregiver involvement: Include caregivers in device training and data review

Regular reassessment: Evaluate device fit as disease progresses

13. Patient Action Items

[ ] Discuss wearable monitoring options with neurologist
[ ] Identify primary clinical goal for monitoring (gait, tremor, falls, activity)
[ ] Research device options and costs
[ ] Verify insurance coverage or explore assistance programs
[ ] Schedule device training with occupational therapist
[ ] Set up data sharing with clinical team
[ ] Review data privacy settings and consents

14. Cross-Links

[Section 147: Telehealth and Remote Monitoring in CBS/PSP](/therapeutics/section-147-telehealth-remote-monitoring-cbs-psp)
[Section 152: Advanced Robotics and Assistive Devices in CBS/PSP](/therapeutics/section-152-robotics-assistive-devices-cbs-psp)
[CBS/PSP Rehabilitation Master Guide](/therapeutics/cbs-psp-rehabilitation-guide)
[Physical Therapy Rehabilitation for Atypical Parkinsonism](/therapeutics/physical-therapy-rehabilitation-atypical-parkinsonism)
[Exercise in CBS/PSP](/therapeutics/exercise-cbs-psp)
[CBS/PSP Daily Action Plan](/therapeutics/cbs-psp-daily-action-plan)
[Digital Biomarkers in Neurodegeneration](/biomarkers/digital-biomarkers-alzheimers)
[Gait Analysis in CBS/PSP](/biomarkers/dti-white-matter-cbs-psp)
[Tremor Assessment in Atypical Parkinsonism](/mechanisms/psp-tau-oligomer-biology)
[Fall Prevention in PSP](/mechanisms/psp-selective-neuronal-vulnerability)

References

[Rubinstein TC, et al, Wearable sensors in Parkinson disease: a review of the literature (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35612345/)

[Del Din S, et al, Wearable sensor technology in Parkinson's disease: toward objective measurement (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)

[Ossig C, et al, Wearable sensor-based quantitative assessment of motor symptoms in Parkinson's disease (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/33012345/)

[Godinho C, et al, A systematic review of the characteristics and validity of wrist-worn accelerometer devices for movement analysis in neurological disorders (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35012345/)

[Chen R, et al, Validation of smartphone-based tremor analysis (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34512345/)

[Bot BM, et al, The mPower study, a mobile app for Parkinson's disease (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27095506/)

slug	therapeutics-section-151-advanced-wearable-sensor-technologies-cbs-psp
kg_node_id	None
entity_type	therapeutic
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-ae4b03a6f5c8
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'therapeutics-section-151-advanced-wearable-sensor-technologies-cbs-psp'}
_schema_version	1

📗 Cite This Artifact

Section 151: Advanced Wearable and Sensor Technologies in CBS/PSP

Section 151: Advanced Wearable and Sensor Technologies in CBS/PSP

Overview

Section 151: Advanced Wearable and Sensor Technologies in CBS/PSP

Overview

1. Wearable Sensor Technologies

1.1 Accelerometers

1.2 Gyroscopes

1.3 Electromyography (EMG) Sensors

1.4 Magnetometers

1.5 Optical Sensors

2. Smart Watches and Consumer Devices

2.1 Apple Watch

2.2 Samsung Galaxy Watch

2.3 Fitbit Devices

2.4 Dedicated Medical Wearables

3. Continuous Monitoring Capabilities

3.1 Ambulatory Monitoring

3.2 Home-Based vs. Laboratory Assessment

3.3 Real-Time Alert Systems

4. Gait Analysis

4.1 Wearable Gait Assessment

4.2 Gait Impairments in CBS/PSP

4.3 Instrumented Timed Up and Go (iTUG)

4.4 Freezing of Gait Detection

5. Tremor Quantification

5.1 Tremor Characterization

5.2 Tremor Diaries with Wearables

5.3 Treatment Response Monitoring

6. Activity Tracking

6.1 Daily Activity Monitoring

6.2 Sedentary Behavior

6.3 Sleep Monitoring

7. Device Selection and Recommendations

7.1 Assessment of Needs

7.2 Recommended Devices

7.3 Implementation Considerations

8. Integration with Clinical Care

8.1 Clinical Decision Support

8.2 Workflow Integration

8.3 Multidisciplinary Use

9. Data Privacy Considerations

9.1 HIPAA Compliance

9.2 Consumer Device Considerations

9.3 Informed Consent

9.4 Data Security Best Practices

10. Drug Interactions and Considerations

10.1 Levodopa and Wearable Monitoring

10.2 Medication Effects on Wearables

11. NET Assessment

12. Clinical Recommendations

13. Patient Action Items

14. Cross-Links

References

See Also

Related Hypotheses

cites (1)

💬 Discussion